ORLANDO -- A gene therapy that could transform CAR T-cell treatment achieved rapid and potentially durable measurable ...

JABSOM Cell and Molecular Biology researcher Dr. Jesse Owens has spent the better part of two decades chasing a vision that ...

An 8-year-old boy made medical history thanks to Columbus doctors. Yet the city where it happened barely registered. Time we ...

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK ...

If approved, gene therapies could fill gaps in patient care left by CFTR modulators, notes GD Healthcare analyst, Vinie Varkey.

Ajinomoto launches CELLiST AAV Production Supplement 1, boosting gene therapy viral vector productivity by 1.3-2x.

Texas Sen. John Cornyn sounded the alarm that a biotech startup firm that has raised some $30 million to study diseases in ...

Qalsody is one step closer to being covered by public Canadian healthcare systems when used to treat adults with ALS with ...

For nearly two decades, researcher Jesse Owens and his team at the University of Hawaiʻi at Mānoa John A. Burns School of Medicine (JABSOM) have ...

Study finds CRISPR/Cas gene editing causes “chromatin fatigue” – another surprise mechanism by which it can produce unwanted ...

Scientists have successfully transplanted gene-edited insulin-producing cells into a man with type 1 diabetes—allowing him to ...

They manage to slow down the progression of Huntington's disease using a gene therapy treatment called AMT 130.